Avion Wealth’s Abeona Therapeutics ABEO Stock Holding History

Avion Wealth’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-85	Closed	–	–	1104
2025 Q1	$0	Buy	+85	New	+$462	﹤0.01%	970

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Avion Wealth's ABEO Position: Q2 2025 in Review

Avion Wealth sold out of Abeona Therapeutics (ABEO) in Q2 2025, closing a stake of 85 shares.

Avion Wealth first reported a position in ABEO in Q1 2025 and held it in 1 quarter. The position peaked at $0 in Q1 2025. 95 funds tracked by Wall St. Rank hold ABEO as of Q2 2025.

Avion Wealth reported no remaining Abeona Therapeutics position as of Q2 2025 after selling out during the quarter.
Avion Wealth sold 85 Abeona Therapeutics shares in Q2 2025.
Avion Wealth first reported a position in Abeona Therapeutics in Q1 2025 and held it in 1 quarter.
Avion Wealth's Abeona Therapeutics position peaked at $0 in Q1 2025.
95 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2025.

Based on Avion Wealth's 13F filing for Q2 2025, filed 25 Jul 2025.